bioequivalence study design of vaginal ring [Design Issues]

posted by Mahesh M – India, 2014-07-16 09:06 (4361 d 13:59 ago) – Posting: # 13272
Views: 5,682

Hi ElMaestro,

That’s nice, actually I work on Ethinyl Estradiol; Etonogestrel (0.015 mg/24 hr; 0.12 mg/24 hr) for US submission.

Dose: single ring for 21 days (Per day ring release 0.015 mg EE and 0.12 mg Etonogestrel) “that mean is like a multiple dose study“ ?

Draft guidance mentioned:

Two way cross over

Bioequivalence based on (90% CI): Ethinyl estradiol and etonogestrel

What is the primary PK parameters ? is it Cmax, AUC0-t and AUC0-∞ or Css (Steady state parameters ) ?

What’s the sampling schedule for this study ?


Regards
Mahesh

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
145 visitors (0 registered, 145 guests [including 43 identified bots]).
Forum time: 23:05 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5